{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:36Z","timestamp":1786372896155,"version":"build-2736575974"},"reference-count":107,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.2215\/cjn.03000509","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T21:35:47Z","timestamp":1254432947000},"page":"1866-1877","source":"Crossref","is-referenced-by-count":24,"title":["The Journey From Vitamin D\u2013Resistant Rickets to the Regulation of Renal Phosphate Transport"],"prefix":"10.2215","volume":"4","author":[{"given":"Barton S.","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Kleeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold J.","family":"Felsenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-32-20230601","first-page":"922","article-title":"Pseudohypoparathyroidism: An example of \u201cSeabright-Bantam syndrome.\u201d","volume":"30","author":"Albright","year":"1942","journal-title":"Endocrinology"},{"key":"R2-32-20230601","first-page":"529","article-title":"Rickets resistant to vitamin D therapy","volume":"54","author":"Albright","year":"1937","journal-title":"Am J Dis Child"},{"key":"R3-32-20230601","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM193704292161701","article-title":"Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females","volume":"216","author":"Albright","year":"1937","journal-title":"N Engl J Med"},{"key":"R4-32-20230601","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00005792-199105000-00007","article-title":"X-linked hypophosphatemia: An appreciation of a classic paper and a survey of progress since 1958","volume":"70","author":"Scriver","year":"1991","journal-title":"Medicine"},{"key":"R5-32-20230601","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005792-195805000-00001","article-title":"A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature","volume":"37","author":"Winters","year":"1958","journal-title":"Medicine"},{"key":"R6-32-20230601","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1172\/JCI100955","article-title":"The effect of vitamin D on calcium and phosphorus metabolism: Studies on four patients","volume":"7","author":"Albright","year":"1938","journal-title":"J Clin Invest"},{"key":"R7-32-20230601","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.ki.5000148","article-title":"The renal Na+\/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone","volume":"69","author":"Bacic","year":"2006","journal-title":"Kidney Int"},{"key":"R8-32-20230601","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ndt\/14.2.333","article-title":"X-linked hypophosphataemia: A homologous disorder in humans and mice","volume":"14","author":"Tenenhouse","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R9-32-20230601","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1096\/fasebj.10.7.8635692","article-title":"The molecular defect in the renal sodium-phosphate transporter expression pathway of Gyro (Gy) mice is distinct from that of hypophosphatemic (Hyp) mice","volume":"10","author":"Collins","year":"1996","journal-title":"FASEB J"},{"key":"R10-32-20230601","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jbmr.5650040407","article-title":"Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia","volume":"4","author":"Meyer","year":"1989","journal-title":"J Bone Miner Res"},{"key":"R11-32-20230601","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/jbmr.5650040411","article-title":"The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy","volume":"4","author":"Meyer","year":"1989","journal-title":"J Bone Miner Res"},{"key":"R12-32-20230601","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI115735","article-title":"Crosstransplantation of kidneys in normal and Hyp mice: Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect","volume":"89","author":"Nesbitt","year":"1992","journal-title":"J Clin Invest"},{"key":"R13-32-20230601","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/ki.1996.468","article-title":"Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse","volume":"50","author":"Lajeunesse","year":"1996","journal-title":"Kidney Int"},{"key":"R14-32-20230601","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/geno.1994.1034","article-title":"Localization of a renal sodium phosphate cotransporter gene to human chromosome 5q35","volume":"19","author":"Kos","year":"1994","journal-title":"Genomics"},{"key":"R15-32-20230601","doi-asserted-by":"crossref","first-page":"F1082","DOI":"10.1152\/ajprenal.0092.2001","article-title":"Murine and human type I Na-phosphate cotransporter genes: Structure and promoter activity","volume":"281","author":"Soumounou","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"R16-32-20230601","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","article-title":"SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis","volume":"78","author":"Bergwitz","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R18-32-20230601","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/154411130401500503","article-title":"The wrickkended pathways of FGF23, MEPE and PHEX","volume":"15","author":"Rowe","year":"2004","journal-title":"Crit Rev Oral Biol Med"},{"key":"R19-32-20230601","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1681\/ASN.2005050573","article-title":"Fibroblast growth factor 23: Roles in health and disease","volume":"16","author":"Imel","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R20-32-20230601","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1210\/me.2002-0113","article-title":"Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression","volume":"16","author":"Bai","year":"2002","journal-title":"Mol Endocrinol"},{"key":"R21-32-20230601","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1359\/JBMR.050212","article-title":"Overexpression of human PHEX under the human \u03b2-actin promoter does not fully rescue the HYP mouse phenotype","volume":"20","author":"Erben","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R22-32-20230601","doi-asserted-by":"crossref","first-page":"F647","DOI":"10.1152\/ajprenal.00354.2002","article-title":"Central control of renal sodium-phosphate (NaPi-2) transporters","volume":"286","author":"Mulroney","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"R23-32-20230601","first-page":"722","article-title":"Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia","volume":"118","author":"Yuan","year":"2008","journal-title":"J Clin Invest"},{"key":"R24-32-20230601","first-page":"287","article-title":"Familial hypophosphatemic rickets showing autosomal dominant inheritance","volume":"7","author":"Bianchine","year":"1971","journal-title":"Birth Defects Orig Artic Ser"},{"key":"R26-32-20230601","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R27-32-20230601","doi-asserted-by":"crossref","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","article-title":"Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism","volume":"289","author":"Shimada","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"R28-32-20230601","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int"},{"key":"R29-32-20230601","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and enhances in vivo biological potency","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"key":"R30-32-20230601","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency","volume":"278","author":"Bai","year":"2003","journal-title":"J Biol Chem"},{"key":"R31-32-20230601","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R32-32-20230601","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-32-20230601","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"R34-32-20230601","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-32-20230601","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"R36-32-20230601","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of FGF23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R37-32-20230601","first-page":"S16","article-title":"The neutralization of FGF-23 ameliorates hypophosphatemia and rickets in Hyp mice [Abstract]","volume":"18","author":"Aono","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R38-32-20230601","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","article-title":"FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate","volume":"284","author":"Bowe","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R39-32-20230601","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","article-title":"FGF23 is processed by proprotein convertases but not by PHEX","volume":"35","author":"Benet-Pages","year":"2004","journal-title":"Bone"},{"key":"R40-32-20230601","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2007","journal-title":"J Biol Chem"},{"key":"R41-32-20230601","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj20030287","article-title":"Human recombinant PHEX has a strict S1\u2032 specificity for acidic residues and cleaves peptides derived from FGF-23 and MEPE","volume":"373","author":"Campos","year":"2003","journal-title":"Biochem J"},{"key":"R42-32-20230601","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MNH.0b013e3282fd6e5b","article-title":"PHEX, FGF23, DMP1 and beyond","volume":"17","author":"Strom","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R43-32-20230601","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","article-title":"Bone as a source of FGF23: Regulation by phosphate?","volume":"35","author":"Mirams","year":"2004","journal-title":"Bone"},{"key":"R44-32-20230601","doi-asserted-by":"crossref","first-page":"e1000154","DOI":"10.1371\/journal.pgen.1000154","article-title":"Genetic evidence of serum phosphate-independent functions of FGF-23 on bone","volume":"4","author":"Sitara","year":"2008","journal-title":"PLoS Genet"},{"key":"R45-32-20230601","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","article-title":"FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization","volume":"285","author":"Quarles","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R46-32-20230601","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bone.2003.10.005","article-title":"MEPE has the properties of an osteoblastic phosphatonin and minhibin","volume":"34","author":"Rowe","year":"2004","journal-title":"Bone"},{"key":"R47-32-20230601","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/jc.2003-032031","article-title":"Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density","volume":"89","author":"Jain","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-32-20230601","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1681\/ASN.2008030315","article-title":"Matrix extracellular phosphoglycoprotein inhibits phosphate transport","volume":"19","author":"Marks","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R49-32-20230601","first-page":"S170","article-title":"The response of MEPE to long-term and short-term phosphate supplementation in healthy volunteers [Abstract]","volume":"18","author":"Allen","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R50-32-20230601","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/geno.2001.6553","article-title":"Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone","volume":"74","author":"Argiro","year":"2001","journal-title":"Genomics"},{"key":"R51-32-20230601","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1681\/ASN.2004121060","article-title":"Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia","volume":"16","author":"Liu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R52-32-20230601","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","article-title":"1\u03b1,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: The final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport","volume":"289","author":"Kolek","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R53-32-20230601","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"FGF23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R54-32-20230601","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","article-title":"Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells","volume":"288","author":"Ito","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R55-32-20230601","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1744-9987.2005.00292.x","article-title":"Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23","volume":"9","author":"Miyamoto","year":"2005","journal-title":"Ther Apher Dial"},{"key":"R56-32-20230601","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI111900","article-title":"Healing of bone disease in X-linked hypophosphatemic rickets\/osteomalacia: Induction and maintenance with phosphorus and calcitriol","volume":"75","author":"Herrell","year":"1985","journal-title":"J Clin Invest"},{"key":"R57-32-20230601","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1126\/science.173.3999.845","article-title":"Serum parathyroid hormone in X-linked hypophosphatemia","volume":"173","author":"Arnaud","year":"1971","journal-title":"Science"},{"key":"R58-32-20230601","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0022-3476(72)80298-1","article-title":"Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets","volume":"81","author":"Lewy","year":"1972","journal-title":"J Pediatr"},{"key":"R59-32-20230601","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1210\/endo-110-3-1030","article-title":"X-linked hypophosphatemic mice are not hypersensitive to parathyroid hormone","volume":"110","author":"Kiebzak","year":"1982","journal-title":"Endocrinology"},{"key":"R60-32-20230601","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jbmr.5650040407","article-title":"Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice","volume":"4","author":"Meyer","year":"1989","journal-title":"J Bone Miner Res"},{"key":"R61-32-20230601","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s004670050669","article-title":"PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia","volume":"13","author":"Blydt-Hansen","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"R62-32-20230601","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-004-1443-y","article-title":"The enigma of hyperparathyroidism in hypophosphatemic rickets","volume":"19","author":"Schmitt","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R63-32-20230601","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1 (I) collagen promoter exhibit growth retardation, osteomalacia and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2007","journal-title":"Endocrinology"},{"key":"R64-32-20230601","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"R65-32-20230601","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"R66-32-20230601","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1681\/ASN.V104878","article-title":"Phosphorus, regulation of plasma calcium and secondary hyperparathyroidism: A hypothesis to integrate a historical and modern perspective","volume":"10","author":"Felsenfeld","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R67-32-20230601","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ki.1991.315","article-title":"Calcemic response to parathyroid hormone in renal failure: Role of calcitriol and the effect of parathyroidectomy","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int"},{"key":"R68-32-20230601","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S8756-3282(99)00263-X","article-title":"Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia","volume":"26","author":"Ishii","year":"2000","journal-title":"Bone"},{"key":"R69-32-20230601","first-page":"910","article-title":"Effect of potent parathyroid extract on calcium balance in infants","volume":"33","author":"Hoag","year":"1927","journal-title":"Am J Dis Child"},{"key":"R70-32-20230601","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1152\/ajplegacy.1933.105.3.621","article-title":"Effect of diet on response to parathyroid extract and vitamin D: IV. The effect of diets of normal calcium and phosphorus content in dogs","volume":"105","author":"Morgan","year":"1933","journal-title":"Am J Physiol"},{"key":"R71-32-20230601","doi-asserted-by":"crossref","first-page":"E700","DOI":"10.1152\/ajpendo.1998.275.4.E700","article-title":"Intrinsic mineralization defect in Hyp mouse osteoblasts","volume":"275","author":"Xiao","year":"1998","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R72-32-20230601","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI112274","article-title":"Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1-alpha-hydroxylase activity in the hypophosphatemic mouse: Evidence for generalized defect of vitamin D metabolism","volume":"77","author":"Nesbitt","year":"1986","journal-title":"J Clin Invest"},{"key":"R73-32-20230601","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1359\/jbmr.2003.18.3.434","article-title":"Abnormal regulation of renal 25-hydroxyvitamin D-1alpha-hydroxylase activity in X-linked hypophosphatemia: A translational or post-translational defect","volume":"18","author":"Fujiwara","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R74-32-20230601","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1172\/JCI105211","article-title":"Effects of serum calcium level and parathyroid extracts on phosphate and calcium excretion in hypoparathyroid patients","volume":"44","author":"Eisenberg","year":"1965","journal-title":"J Clin Invest"},{"key":"R75-32-20230601","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1507\/endocrj.K06-156","article-title":"Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: Its important role in serum phosphate regulation","volume":"54","author":"Yamashita","year":"2007","journal-title":"Endocrine J"},{"key":"R76-32-20230601","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R77-32-20230601","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.ki.5000020","article-title":"Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats","volume":"69","author":"Nagano","year":"2006","journal-title":"Kidney Int"},{"key":"R78-32-20230601","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM197209072871003","article-title":"Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia","volume":"287","author":"Glorieux","year":"1972","journal-title":"N Engl J Med"},{"key":"R79-32-20230601","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"R80-32-20230601","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.mnh.0000172717.49476.80","article-title":"Role of fibroblast growth factor 23 in health and in chronic kidney disease","volume":"14","author":"Fukagawa","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R81-32-20230601","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"R82-32-20230601","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","article-title":"Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men","volume":"70","author":"Nishida","year":"2006","journal-title":"Kidney Int"},{"key":"R83-32-20230601","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2007060673","article-title":"Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD","volume":"19","author":"Isakova","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R84-32-20230601","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1359\/jbmr.080417","article-title":"Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23","volume":"23","author":"Yamazaki","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R85-32-20230601","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"R86-32-20230601","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0272-6386(04)00817-0","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism","volume":"44","author":"Sato","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R87-32-20230601","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R88-32-20230601","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","article-title":"Post-transplant hypophosphatemia: Tertiary \u201chyper-phosphatoninism\u201d?","volume":"70","author":"Bhan","year":"2006","journal-title":"Kidney Int"},{"key":"R89-32-20230601","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1210\/jc.2005-1606","article-title":"Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak","volume":"91","author":"Rendina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R90-32-20230601","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1681\/ASN.2007121301","article-title":"FGFR3 and FGFR4 do not mediate renal effects of FGF23","volume":"19","author":"Liu","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R91-32-20230601","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.mnh.0000232885.81142.83","article-title":"Klotho as a regulator of fibroblast growth factor signaling and phosphate\/calcium metabolism","volume":"15","author":"Kuro-o","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R92-32-20230601","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23","volume":"146","author":"Yu","year":"2002","journal-title":"Endocrinology"},{"key":"R93-32-20230601","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/427956","article-title":"Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation","volume":"76","author":"White","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R94-32-20230601","first-page":"S4","article-title":"A missense mutation in FGFR1 causes a novel syndrome: Craniofacial dysplasia with hypophosphatemia","volume":"18","author":"Evans","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R95-32-20230601","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by Klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"R96-32-20230601","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"R97-32-20230601","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"R98-32-20230601","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molmed.2006.05.002","article-title":"Hypervitaminosis D and premature aging: Lessons learned from FGF23 and Klotho mutant mice","volume":"12","author":"Razzaque","year":"2006","journal-title":"Trends Mol Med"},{"key":"R99-32-20230601","doi-asserted-by":"crossref","first-page":"F769","DOI":"10.1152\/ajprenal.00248.2006","article-title":"Correlation between hyperphosphatemia and type II Na\/Pi cotransporter activity in klotho mice","volume":"292","author":"Segawa","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R100-32-20230601","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2008070783","article-title":"Initial FGF23-mediated signaling occurs in the distal convoluted tubule","volume":"20","author":"Farrow","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R101-32-20230601","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/jn\/131.12.3182","article-title":"The progression of aging in Klotho mutant mice can be modified by dietary phosphorus and zinc","volume":"131","author":"Morishita","year":"2001","journal-title":"J Nutr"},{"key":"R102-32-20230601","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1073\/pnas.73.12.4667","article-title":"Hypophosphatemia: Mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets","volume":"73","author":"Eicher","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R103-32-20230601","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/archinte.1974.00320210159025","article-title":"Renal transplantation in hypophosphatemia with vitamin D-resistant rickets","volume":"134","author":"Morgan","year":"1974","journal-title":"Arch Intern Med"},{"key":"R104-32-20230601","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02411222","article-title":"Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalacia","volume":"34","author":"Lyles","year":"1982","journal-title":"Calcif Tissue Int"},{"key":"R105-32-20230601","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF02553712","article-title":"Abnormal parathyroid function in the X-linked hypophosphatemic mouse","volume":"37","author":"Posillico","year":"1985","journal-title":"Calcif Tissue Int"},{"key":"R106-32-20230601","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.273.22.13729","article-title":"Cloning of human Pex cDNA: Expression, subcellular localization, and endopeptidase activity","volume":"273","author":"Lipman","year":"1998","journal-title":"J Biol Chem"},{"key":"R107-32-20230601","doi-asserted-by":"crossref","first-page":"F739","DOI":"10.1152\/ajprenal.00321.2003","article-title":"Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3","volume":"286","author":"Brewer","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"R108-32-20230601","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1\u03b1-hydroxylase in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"key":"R109-32-20230601","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ki.2008.642","article-title":"Phosphate and the parathyroid","volume":"75","author":"Silver","year":"2009","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-200911000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:38:59Z","timestamp":1786369139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-200911000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":107,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03000509","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}